The therapeutic handling of autoimmune liver disease is limited because basic mechanistic insights into immunologically mediated pathophysiology have not yet been translated into standard pharmacological treatments. A future expansion of the incidence of autoimmune liver diseases is anticipated because of growing rates of exposure to an increased variety of xenobiotics of dietary, pharmaceutical or environmental origin.
This book, the proceedings of an International Falk Workshop held in Konstanz, Germany, January 23-24, 1997, aims to share front-line thinking among immunologists,...

The serene phrase, Lest I forget thee, glutathione ..., coined by the Kosowers (1) to describe the state in the 1960's, must be replaced now by something like "Inevitable GSH" in order to characterize the current situation. The surge in interest on the ubiquitous tripeptide has been ama- zing, with publications on GSH running at rates as high as one per day, so that it seemed appropriate to convene international experts for a discussion of recent develop- ments this year. Unlike the two previous meetings in this decade held in Tlibingen in 1973 (2) and in santa Ynez in 1975 (3), the scope was...